Further, CD103+ DCs are a distinct DC population that is uniquely dependent on IRF8 and Batf3 transcription factors and predominantly expresses CCR7 in human tumors, expression of which was used as a molecular proxy for CD103+ DCs in clinical tumor gene expression data sets (47, 48). Here, IRF8 is linked to neoplasm.